Literature DB >> 29600480

Fragmented particles containing octreotide acetate prepared by spray drying technique for dry powder inhalation.

Ailin Hou1, Lu Li1, Ying Huang1, Vikramjeet Singh1, Chune Zhu2, Xin Pan1, Guilan Quan3, Chuanbin Wu1.   

Abstract

Dry powder inhalers (DPIs) have been proposed as an alternative administration route for protein and peptide drugs. However, DPI particles are easy to aggregate due to the strong interactions between the particles, leading to poor aerosolization performance. In this study, fragmented particles containing octreotide acetate (OA) were prepared by spray drying technique for dry powder inhalation, which were expected to decrease the particle-particle interaction by reducing the contact sites. Mannitol and ammonium carbonate were used as protein stabilizer and fragment-forming agent, respectively. The obtained fragmented particles presented larger particle size, lower density, better dispersibility, and well in vitro aerodynamic behavior (emitted dose > 97%, fine particle fraction ≈ 40%). The circular dichroism spectrum results indicated that OA maintained the stability throughout the spray drying process. The relative bioavailability of dry powder inhalation (DPI) compared with subcutaneous injection of commercial product was up to 88.0%, demonstrating the feasibility of DPI for OA delivery. These results confirmed that the proposed fragmented particles had great potential for pulmonary delivery of protein and peptide drugs in a painless, rapid, and convenient manner.

Entities:  

Keywords:  Ammonium carbonate; Dry powder inhalation; Fragmented particles; Octreotide acetate; Spray drying

Mesh:

Substances:

Year:  2018        PMID: 29600480     DOI: 10.1007/s13346-018-0515-7

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  27 in total

Review 1.  Amorphous solid dispersion technique for improved drug delivery: basics to clinical applications.

Authors:  Dinesh Kumar Mishra; Vinod Dhote; Arpit Bhargava; Dinesh Kumar Jain; Pradyumna Kumar Mishra
Journal:  Drug Deliv Transl Res       Date:  2015-12       Impact factor: 4.617

2.  The effect of particle shape and size on cellular uptake.

Authors:  M Zheng; J Yu
Journal:  Drug Deliv Transl Res       Date:  2016-02       Impact factor: 4.617

Review 3.  Particle engineering for pulmonary drug delivery.

Authors:  Albert H L Chow; Henry H Y Tong; Pratibhash Chattopadhyay; Boris Y Shekunov
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

4.  Do co-spray dried excipients offer better lysozyme stabilisation than single excipients?

Authors:  Wendy L Hulse; Robert T Forbes; Michael C Bonner; Matthias Getrost
Journal:  Eur J Pharm Sci       Date:  2008-01-05       Impact factor: 4.384

Review 5.  MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases.

Authors:  Kamal Dua; Nicole G Hansbro; Paul S Foster; Philip M Hansbro
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

6.  In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers.

Authors:  Daniela Traini; Paul M Young; Philippe Rogueda; Robert Price
Journal:  Pharm Res       Date:  2006-11-14       Impact factor: 4.200

7.  Enhanced delivery of octreotide to the brain via transnasal iontophoretic administration.

Authors:  Eduard N Lerner; Elske H van Zanten; Gregory R Stewart
Journal:  J Drug Target       Date:  2004-06       Impact factor: 5.121

8.  Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis.

Authors:  Philip Chi Lip Kwok; Adam Grabarek; Michael Y T Chow; Yun Lan; Johnny C W Li; Luca Casettari; A James Mason; Jenny K W Lam
Journal:  Int J Pharm       Date:  2015-07-04       Impact factor: 5.875

9.  Steroid/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery.

Authors:  Frederic Tewes; Krzysztof J Paluch; Lidia Tajber; Karan Gulati; Devesh Kalantri; Carsten Ehrhardt; Anne Marie Healy
Journal:  Eur J Pharm Biopharm       Date:  2013-04-04       Impact factor: 5.571

10.  Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes.

Authors:  Kavitha Koushik; Devender S Dhanda; Narayan P S Cheruvu; Uday B Kompella
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

View more
  3 in total

1.  Preparation of an oil suspension containing ondansetron hydrochloride as a sustained release parenteral formulation.

Authors:  Thi-Thao-Linh Nguyen; Van-An Duong; Han-Joo Maeng; Sang-Cheol Chi
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

2.  A homogenous nanoporous pulmonary drug delivery system based on metal-organic frameworks with fine aerosolization performance and good compatibility.

Authors:  Yixian Zhou; Boyi Niu; Biyuan Wu; Sulan Luo; Jintao Fu; Yiting Zhao; Guilan Quan; Xin Pan; Chuanbin Wu
Journal:  Acta Pharm Sin B       Date:  2020-08-03       Impact factor: 11.413

Review 3.  Spray-Dried Inhalable Powder Formulations of Therapeutic Proteins and Peptides.

Authors:  Basanth Babu Eedara; Wafaa Alabsi; David Encinas-Basurto; Robin Polt; Heidi M Mansour
Journal:  AAPS PharmSciTech       Date:  2021-06-18       Impact factor: 4.026

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.